Inventor · disambiguated record
Douglas C. Marchion
Also filed as: MARCHION DOUGLAS · MARCHION DOUGLAS C
4 granted patents·1 pending application·0 citations·filing 2010–2018
53Inventor score
Technology areasG01N
Top patents by PatentIndex Score
5 records- 0156US9983209B2Method of diagnosing, treating and determining progression and survival of cancer cells using BCL-2 antagonist of cell death (BAD) pathway gene signatureH LEE MOFFITT CANCER CT & RES·Filed 2014·Granted May 29, 2018·0 cites·1 claims
- 0255US2018238892A1Method of diagnosing, treating and determining progression and survival of cancer cells using bcl-2 antagonist of cell death (bad) pathway gene signatureH LEE MOFFITT CANCER CT & RES·Filed 2018·Application pending·0 cites
- 0345US9809858B2O-glycan pathway ovarian cancer signatureH LEE MOFFITT CANCER CT & RES·Filed 2013·Granted Nov 7, 2017·0 cites·9 claims
- 0442US9528982B2Bad phosphorylation determines ovarian cancer chemo-sensitivity and patient survivalH LEE MOFFITT CANCER CT & RES·Filed 2013·Granted Dec 27, 2016·0 cites·15 claims
- 0532US9063143B2Cancer platinum resistance detection and sensitization methodLANCASTER JOHNATHAN·Filed 2010·Granted Jun 23, 2015·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Douglas C. Marchion files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →